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Abstract
Background: Resveratrol is a plant-derived polyphenol with purported protecting action on various disorders associated
with aging. It has been suggested that resveratrol could exert its protective action by acting on specific plasma membrane
polyphenol binding sites (Han Y.S., et al. (2006) J Pharmacol Exp Ther 318:238–245). The purpose of this study was to
investigate, in human skin, the possible existence of specific binding sites that mediate the protective action of resveratrol.
Methods and Findings: Using human skin tissue, we report here the presence of specific [
3H]-resveratrol binding sites (KD =
180 nM) that are mainly located in the epidermis. Exposure of HaCaT cells to the nitric oxide free radical donor sodium
nitroprusside (SNP; 0.3–3 mM) resulted in cell death which was reduced by resveratrol (EC50 =14.7 mM), and to a much lesser
extent by the resveratrol analogue piceatannol (EC50 =95mM) and epigallocatechin gallate (EC50 =200mM), a green-tea
derived polyphenol. The protective action of resveratrol likely relates to its anti-apoptotic effect since at the same range of
concentration it was able to reduce both the number of apoptotic cells as well as mitochondrial apoptotic events triggered by
SNP.
Conclusion: Taken together, these findings suggest that resveratrol, by acting on specific polyphenol binding sites in
epidermis, may be useful to prevent skin disorders associated with aging.
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Introduction
Resveratrol (3,5,49-trihydroxystilbene) is a naturally occurring
polyphenol and is particularly found in grape skin, nuts and
pomegranate. It has been hypothesized that resveratrol contributes
to the ability of polyphenols rich Mediterranean diet to reduce the
incidence of age-related diseases such as coronary heart disease
[1,2], cancer [3] and dementia [4]. In support of this hypothesis,
resveratrol displays a broad variety of beneficial effects including
cardioprotective, neuroprotective, antimicrobial and chemopreven-
tive properties [5–9]. Resveratrol, for example has been shown to
down-regulate vasoactive peptides such as endothelins [10], to
inhibit oxidized low-density lipoprotein [11] and cyclooxygenase
[2], to inhibit the clearance and neurotoxicity of beta-amyloid (Aß)
[12,13], to modulate apoptotic signalling pathways [8] and to
activate sirtuin and AMP-activated protein kinase which are
believed to be involved in the caloric restriction-longevity effect
[14,15]. We have previously reported that resveratrol shared with
other polyphenols (e.g. quercetin and catechins), the ability to block
neuronal hippocampal cell death against the toxicity induced by
nitric oxide (NO) [16] and Aß peptides [13], raising the possibility
for polyphenols to be beneficial in the prevention of age-related
neurodegenerative disorders [17–20]. Membrane binding and
autoradiographic studies on rat brain suggest the existence of
polyphenol specific plasma membrane binding sites, possibly
underlying the neuroprotective action of polyphenols [21].
The characterization of resveratrol as a promising agent with
anti-aging properties, in addition to many other health benefits,
has prompted interest in investigating its protective effects against
factors known to alter the course of normal skin aging [22–24].
Here, we hypothesize that resveratrol could exert its protective
actions through specific binding sites located in the epidermis.
Accordingly, the main objective of the present study was to
identify and characterize the presence of specific binding sites for
[
3H]-resveratrol in human skin tissue. Abnormal increase in NO
release has been reported to be involved in premature skin aging,
in part via its stimulatory effects on reactive oxygen species and
apoptotic pathways [25–28]. Using human keratinocytes cell line
(HaCaT), we investigated the protective effects of resveratrol
against cell death induced by sodium nitroprusside (SNP), a well
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12935known NO releasing with purported toxic and apoptotic effects in
keratinocytes [29].
Results
[
3H]-Resveratrol binding sites in human skin sections and
in HaCaT cells
We aim to determine first the presence and distribution of [
3H]-
resveratrol binding sites using autoradiography. As shown in
Figure 1A, significant amount of specific [
3H]-resveratrol labeling
was observed in the epidermis and to a much lesser extent in the
dermis. The intensity of the signal obtained with [
3H]-resveratrol
was dependent on the concentration of radioligand used (Fig. 1A).
Similarly, the differential distribution of [
3H]-resveratrol binding
sites in human sections exposed to liquid emulsion indicated that
most of the [
3H]-resveratrol binding sites are found in granular
keratinocytes, which represent more than 90% of cells in the
epidermis (Fig. 1B). Quantification of [
3H]-resveratrol binding
obtained from human skin sections confirmed that the epidermis
contained much higher amounts of specific [
3H]-resveratrol
binding sites as compared to the dermis (Table 1) with an
apparent affinity (KD) of 180650 nM (Fig. 2). Additionally,
competition binding experiments on human skin sections revealed
that resveratrol competed for 50% of specific [
3H]-resveratrol
(30 nM) binding sites with a Ki value of 2.660.7 and 1.560.6 mM
in the epidermis and dermis, respectively, which are highly similar
to low affinity sites observed in brain homogenates (Fig. 3; see also
[21]). Moreover, the presence of resveratrol binding sites has been
also observed in human immortalized keratinocyte HaCaT cells,
and isotherm saturation binding experiments revealed the
presence of high affinity sites (KD of 240 nM; Fig. 4). These data
confirm the presence of [
3H]-resveratrol binding sites in
keratinocyte cells and has been further used to investigate the in
vitro protective effects of resveratrol against SNP-induced toxicity.
Resveratrol protects HaCaT cells against SNP-induced
toxicity
We then performed a functional assay to evaluate the capacity
of resveratrol to protect HaCaT cells against the toxicity induced
by the NO releasing SNP. Treatment of HaCaT cells with SNP
(0.3–3 mM) inhibited the growth of HaCaT cells in a concentra-
tion dependent manner, as evaluated by the MTT and calcein
assays (Fig. 5A, B). Both assays showed that resveratrol (1–30 mM)
strongly attenuated SNP-induced toxicity, producing a significant
effect at 10 mM and a maximal one at the highest concentration
tested (Fig. 5A, B).
The number of SNP-treated cells stained with SYTO 16
increased, indicating that SNP exerted an apoptotic effect on
HaCaT cells (Fig. 6A). The increase in apoptotic cells was reduced
when treated with resveratrol (1–30 mM) with a significant
inhibitory effect at 1 mM (Fig. 6A). The JC1 assay confirmed the
apoptotic effect of SNP resulting in the loss of mitochondrial
Figure 1. Photomicrographs of the autoradiographic distribution of [
3H]-resveratrol binding sites in human skin. Upper panel (A).
Human skin sections were incubated during 8 months with [
3H]-resveratrol (25, 60 and 130 nM), stained with hematoxylin/eosin and visualized using
a microscope. Higher levels of silver grains were observed in the epidermis as compared to the dermis. Total and non-specific binding represents
[
3H]-resveratrol binding with or without cold resveratrol (100 mM), respectively. Lower panel (B). Photomicrographic distribution of human skin
incubated with [
3H]-resveratrol (25, 60 and 130 nM) and exposed to liquid emulsion for 8 months. The widespread distribution of silver grains (black
dots) in the epidermis suggested that [
3H]-resveratrol binding sites are mostly located in keratinocytes, which makes about 90% of skin epidermis.
The number of silver grains is similar in undifferentiated (cells in the basal layer) and differentiated (cells at the surface of the skin) keratinocytes.
doi:10.1371/journal.pone.0012935.g001
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green fluorescence intensity ratio (Fig. 6B). Resveratrol reversed
the loss of MMP, with significant effect at the concentrations with
an anti-apoptotic effect (Fig. 6B).
The DCF assay indicated that a 5-hour exposure to SNP (1 and
3 mM) causes a significant increase (*P,0.01) in ROS accumu-
lation (106 and 198% above control values, respectively; Fig.7A).
SNP-stimulated ROS production was significantly attenuated by
resveratrol (1–30 mM) in the range of concentrations that
protected hippocampal cells against SNP-induced toxicity
(Fig. 7A). The effect of resveratrol was significant at 3 mM (vs
SNP 1 mM) and 30 mM (vs SNP 3 mM), whereas ROS
accumulation in cell cultures treated with resveratrol (10–30 mM)
alone was slightly, but significantly, decreased compared to
vehicle-treated control groups (Fig. 7A). Additionally, a 5-hour
exposure to SNP (1–3 mM) increased nitrite level in the culture
medium (P,0.01). However, resveratrol (1–30 mM) failed to
attenuate NO production at the concentrations that protected
HaCaT cells against SNP (Fig. 7B).
Comparative effects of polyphenols against SNP-induced
cell death and ROS accumulation
We compared the antioxidant properties of various polyphenols
[(i.e. resveratrol and its analog piceatannol, epicatechin and its
gallate ester epigallocatechin gallate (EGCG)] and their capacity to
block the toxicity of SNP in HaCaT cells, using the DCF and
calcein assays, respectively. Among the polyphenols tested here,
resveratrol was most effective to protect cells against SNP-induced
toxicity with an EC50 of 14.7 mM, followed by epicatechin
(EC50=58.9 mM), while piceatannol and epigallocatechin gallate
(EGCG) were less effective (EC50=94 and 140 mM, respectively)
(Fig. 8A). Epicatechin was the most potent to inhibit ROS with an
EC50 value of 0.11 mM followed by resveratrol (EC50=5.9 mM)
and piceatannol (EC50=29.4 mM), while EGCG failed to show
antioxidant properties (EC50.100 mM) (Fig. 8B). The antioxidant
activity of resveratrol and other polyphenols did not correlate
(r=0.16) with their protective activity against SNP-induced
toxicity, suggesting that the protective effects exhibited by
resveratrol and congeners are not associated with their ability to
block ROS accumulation generated by SNP.
Resveratrol inhibits SNP-induced both caspases 3 and 9
activities induced by SNP, but the p38MAPK pathway in
theses processes
ELISA assays were performed to investigate whether the
neuroprotective action of resveratrol involved a modulation of
the activity of caspases and p38 MAPK, two intracellular effectors
that have been reported to be involved in the apoptotic effect of
NO production (30). The caspase-3 inhibitor (5 mM) significantly
increased cell viability compared to 2 mM SNP-treated cells
[59.565 vs 26.262; p,0.01 (calcein values)], whereas the caspase-
9 inhibitor (5 mM) was not effective [36.962v s3 2 62; NS (calcein
values)]. A role for caspases in NO-induced apoptosis in HaCaT
cells was confirmed by ELISA as SNP (0.5–3 mM) increased the
activity of both caspases-3 and -9 with a significant effect at 1 mM
and 0.5 mM, respectively (Fig. 9A,B). In a concentration-
Figure 2. Scatchard transformation of data presented in
Table 1. The affinity (KD) and maximal binding capacity (Bmax) of
the saturation isotherms were estimated by Scatchard transformation of
12 sections from 3 human skins.
doi:10.1371/journal.pone.0012935.g002
Figure 3. Competition binding profile of resveratrol against
[
3H]-resveratrol binding site in human skin and brain homog-
enates. Brain homogenates and human skin sections were incubated
with [
3H]-resveratrol in the presence of increasing concentration of cold
resveratrol (0.1 nM–100 mM). Each point represents the mean6SEM of
data obtained from three to five determinations, each performed in
triplicate and expressed as percentage of specific binding.
doi:10.1371/journal.pone.0012935.g003
Table 1. Quantitative distribution of [
3H]-resveratrol binding
in human skin.
[
3H]-Resveratrol
Specific binding sites (nCi/mg tissue wet
weight)
Epidermis Dermis
25 nM 0.57760.04 0.00960.011
60 nM 1.15660.09 0.06660.06
130 nM 2.00360.15 0.13360.08
Levels of [
3H]-resveratrol binding were quantified using a MCID image analysis
(St. Catherines, ON, Canada). Total [
3H]-resveratrol binding was subtracted from
adjacent sections incubated in the presence of 100 mM unlabelled resveratrol
and expressed as specific [
3H]-resveratrol binding sites (nCi/mg tissue, wet
weight). Data represent the mean 6 SEM of 12 sections obtained from 3
different subjects.
doi:10.1371/journal.pone.0012935.t001
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caspase-3 with a significant effect at 10 mM (Fig. 9C). Moreover,
resveratrol was able to completely block SNP-induced caspase-9
activity (Fig. 9D). Co-exposure of 2 mM SNP with either SB
203580 (25 mM) or SB 202190 (25 mM), two inhibitors of p38
MAP kinase [30], resulted in an increase in cell viability (Table 2).
However, resveratrol failed to regulate either form of p38 MAPK
at concentrations that protected HaCaT cells (Table 2).
Microarray analysis of genes related to NO signalling
pathway
A quantitative real-time RT-PCR was performed to evaluate if
resveratrol was able to modulate the expression of various genes
known to be involved in NO signalling pathway. Among all the
genes investigated here, those that display fold change higher than
threshold are indicated in Table S1. HaCaT cells treated with SNP
(1 mM) show that 10 genes were upregulated while 6 genes were
down regulated. Resveratrol (10 mM) was able to restore the
expression of SNP up-regulated (e.g. interleukin 8, jun oncogene,
nitric oxide synthase 3, NADPH dehydrogenase, quinone 1) or
down-regulated (e.g. catalase, glutathione peroxidase) genes. More-
over, resveratrol was independently able to increase gene expression
including glutathione peroxidase, keratin 1 and oxidation resistance
1 and decrease the expression of ribosomal protein L13a (Table S1).
Discussion
In the present study we describe for the first time, the existence
of [
3H]-resveratrol specific binding in human skin and human
keratinocytes cell line (HaCaT). Receptor autoradiography
revealed that specific [
3H]-resveratrol binding is present in human
skin tissue with the highest level of labelling seen in the epidermis
and apparent affinity (KD) of 180650 nM. The presence of
resveratrol binding sites has been also observed in HaCaT cells,
and isotherm saturation binding experiments revealed the
presence of high affinity sites (KD of 240 nM). Interestingly, we
have previously demonstrated the existence of a high affinity
polyphenols binding in the brain, with an apparent affinity (KD)o f
220 nM [21], which is quite similar to that reported here in both
human skin tissue and HaCaT cells. Furthermore, competition
binding experiments have shown that resveratrol was able to
inhibit specific [
3H]-resveratrol binding sites in the epidermal and
dermal layers with Ki values of 2.6 and 1.5 mM, respectively,
which are highly similar to low affinity sites observed in brain
homogenates (present data manuscript; see also [21]. However,
the fact that we could not detect a significant proportion of binding
in the high affinity state in the human skin suggest that binding
sites in high affinity state only represent a small proportion of total
binding in the human skin. Further investigation will be required
to identify the nature of resveratrol binding sites observed in
human skin.
Numerous studies have demonstrated that resveratrol show
potent protective effects in various models of toxicity [13,16,20]
including toxicity induced by NO releasing SNP [16]. Similarly,
resveratrol protected HaCaT cells exposed to SNP, suggesting its
ability to block the deleterious events induced by NO overproduc-
tion, a process relevant to premature skinaging occurring uponlong
termUV exposure [25]. We compared the antioxidant properties of
Figure 4. Typical profile of saturation binding isotherms of [
3H]-resveratrol in HaCaT cells. Binding experiments were performed at 4uCi n
the presence or the absence of 100 mM unlabelled resveratrol; specific (round points) binding represents the difference between total (square points)
and non-specific (triangle points) binding. Insert shows the mathematical transformation as Scatchard plots of the binding isotherms of [
3H]-
resveratrol. Each point was done in triplicate and repeated 3 times.
doi:10.1371/journal.pone.0012935.g004
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in HaCaT cells. Among the polyphenols tested here, resveratrol was
the most effective to protect cells against SNP-induced toxicity with
an EC50 of 14.7 mM followed by epicatechin (EC50=58.9mM),
while piceatannol and EGCG were less effective (EC50=94 and
140 mM, respectively). This is in agreement with previous studies
reportinga protective actionofresveratrol and EGCG against SNP-
induced toxicity at the same range of concentration [31].
Furthermore, competition binding experiments have shown that
resveratrol was the most potent competitor in HaCaT cells
withmmolar affinity (resveratrol . piceatannol . EGCG) (data
not shown). Several studies have shown that NO-induced toxicity is
Figure 5. Effect of resveratrol against cell death induced by SNP in HaCaT cells. Cells were exposed to SNP (0.3–3 mM) in the presence or
absence of resveratrol (1–30 mM). Cell viability was determined 24 hours later using both the MTT and calcein AM assays. Values represent mean 6
SEM of at least three separate experiments. *p,0.05, **p,0.01 comp.
doi:10.1371/journal.pone.0012935.g005
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yielding highly cytotoxic reactive oxygen species (ROS), peroxyni-
trite.Thismolecule is degraded to produce nitrogen dioxideand the
radical hydroxyl, leading to DNA damage [32]. However, the
purported antioxidant activities and ROS scavenging properties of
resveratrol do not fully explain its protective capacity. Indeed, the
antioxidant properties of the polyphenols tested here did not
correlate to their ability to protect HaCaT cells against SNP-
induced toxicity. Moreover, resveratrol was unable to modulate the
activity of nitric oxide synthase (NOS) elicited by SNP (as measured
by nitrite accumulation), indicating that its protective action is not
likely to be directly associated to the inhibition of NOS. This is in
Figure 6. Effect of resveratrol against apoptotic events induced by SNP in HaCaT cells. Cells were exposed to SNP (0.3–3 mM) in the
presence or absence of resveratrol (1–30 mM). Cell viability was determined 24 hours later using both the SYTO 16 (A) and JC-1 (B) assays. Values
represent mean 6 SEM of at least three separate experiments. *p,0.05, **p,0.01 compared to groups treated with SNP alone. +p,0.05 compared
to control group.
doi:10.1371/journal.pone.0012935.g006
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(10 mM) failed to inhibit the production of NO in hippocampal
cells [16]. Taken together, this suggests that the protective effect of
resveratrol observed in the present model does not involve its ROS
scavenging properties but rather a modulation of intracellular
effectors.
In addition to their antioxidant properties, polyphenols such as
resveratrol have been reported to modulate the properties of
markers of apoptosis [33,34] suggested to be activated during NO-
mediated cell injury [25]. Accordingly, SNP increased the activity
of the apoptotic markers such as caspases 3 and 9, which was
significantly reduced in the presence of resveratrol at the same
Figure 7. Effect of resveratrol against ROS (A) and nitrite (B) accumulation induced by SNP in HaCaT cells. Cells were exposed to SNP (1
and 3 mM) in the presence or absence of resveratrol (1–30 mM). ROS and nitrite accumulation was determined 5 hours later using the DCF assay and
the Griess reagent respectively. Values represent mean 6 SEM of at least four separate experiments. *p,0.05, **p,0.01 compared to groups treated
with 1 mM SNP only. #p,0.05, ##p,0.01 compared to groups treated with 3 mM SNP alone. +p,0.05 compared to control group.
doi:10.1371/journal.pone.0012935.g007
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with previous findings reporting that the polyphenol 3,49-DHF
was found to exert an anti-apoptotic effect on etoposide-induced
cell death of HaCaT cells [35]. This also implies that the
inhibitory effect of resveratrol on increased activity of caspase-3 - a
critical effector of mitochondrial events in apoptosis [26] could
explain at least in part, its protective action against the toxic effect
of SNP. In support of this hypothesis, we report here that
resveratrol reduced the increase in number of apoptotic cells and
also reversed the loss of mitochondrial membrane potential
initiated by SNP. Moreover, treatment with a caspase-3 inhibitor
significantly increased cell viability, while an inhibitor of caspase-9
was ineffective, indicating that the activation of caspase-3 (a
caspase effector) is a crucial step leading to the apoptotic cell death
induced by SNP.
It has been reported that p38 MAPK is one of the most
prominent protein kinase involved in NO-induced apoptosis
upstream of caspase activation [30]. In support of this hypothesis,
we show that (1) SNP-triggered cell death was reduced in the
presence of two inhibitors of p38 MAPK (i.e. SB 203580 and SB
202190) [30] and (2) SNP activated both phospho-p38 and the
total level of p38 MAPK. However, resveratrol failed to regulate
either form of p38 MAPK at concentrations that protected
HaCaT cells, suggesting that the protective action of resveratrol
did not involve this protein kinase. The lack of additive effects of
resveratrol and p38 MAP kinase inhibitors in protecting HaCaT
cells against SNP-induced cell death suggests that inhibition of
caspase-3 by resveratrol depends on p38 MAP kinase activity. It
thus appears that p38 MAP kinase is not directly involved in the
mitochondrial injury induced by SNP.
Figure 8. Comparison of polyphenols against cell death (A) and ROS accumulation (B) induced by SNP in HaCaT cells. Cells were
exposed to SNP (2 mM) in the presence or absence of polyphenols (0.3–30 mM). ROS accumulation was determined 5 hours later using the DCF assay.
Values represent mean 6 SEM of at least three separate experiments. *p,0.05, **p,0.01 compared to groups treated with 2 mM SNP alone.
doi:10.1371/journal.pone.0012935.g008
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resveratrol (10 mM) reversed SNP-altered expression of genes that
either protect cells against oxidative stress (e.g. catalase, glutathi-
one peroxidase) or promote oxidative stress (e.g. NADPH
dehydrogenase quinone 1) and inflammation (e.g. interleukin 8
and NOS). Moreover, resveratrol by itself upregulated the
expression of genes that protect against oxidative damage (i.e.
glutathione peroxidase, oxidation resistance 1) or were involved in
keratinocyte differentiation [i.e. keratin 1, [36]] and cutaneous
wound healing [(i.e. vascular endothelial growth factor A, [37]].
In summary, here we show that resveratrol possibly exerts its
protective effect on epidermal cells by binding on specific
polyphenol binding sites. Intracellular mechanisms underlying
the protective effect of resveratrol are not solely due to its
antioxidant activities but also involve its inhibitory action on
apoptosis, a downstream mitochondrial dysfunction, as revealed
by the ability of resveratrol to reduce caspase-3 activity as well as
the number of apoptotic HaCaT cells and to prevent mitochon-
drial dysfunctions. It will be of interest to confirm these results
using primary keratinocytes from human samples. Considering
that NO is a key mediator implicated in a broad range of age-
related skin damages, these findings suggest that resveratrol could
delay and even prevent the normal course of skin aging by
blocking apoptotic events and mitochondrial dysfunctions. These
Figure 9. Effect of resveratrol against SNP-induced caspase-3 and caspase-9 activation in HaCaT cells. Cells were exposed to SNP (0.12–
3 mM) in the presence or absence of resveratrol (1–30 mM). Caspase-3 and -9 activities were measured 24 hours later using colorimetric assay kits.
Values represent mean 6 SEM of at least three separate experiments. +p,0.05, ++p,0.01 compared to control group. *p,0.05, **p,0.01 compared
to groups treated with SNP alone.
doi:10.1371/journal.pone.0012935.g009
Table 2. Effect of resveratrol and SB 203580 on p38 MAPK
levels induced by SNP in HaCaT cells.
Treatment
Relative level of
Phospho-p38 MAPK
(% of control)
Relative level of
total p38 MAPK
(% of control)
Control 10061 10062
SNP (2 mM) 12563 11862
+ Resveratrol (20 mM) 124 6 4 12063
Control 10061 10062
SNP (2 mM) 11963 11963
+ SB 203580 (25 mM) 105 6 3* 10263*
Values represent mean 6 SEM of four separate experiments.
*p,0.01 compared to groups treated with SNP alone.
doi:10.1371/journal.pone.0012935.t002
Resveratrol and Protection
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resveratrol with a higher affinity towards polyphenols binding sites,
leading to pertinent effects in reducing skin aging.
Materials and Methods
Materials
Human immortalized HaCaT keratinocytes cells were purchased
from CLS Cell Lines Service (Eppelheim, Germany). Materials used
for cell cultures were obtained from Invitrogen (Burlington, ON,
Canada). Fluorescent dyes (calcein, SYTO16 green, 29,79-dichloro-
fluorescein diacetate, dye 5,59,6,69-tetrachloro-1,19,3,39 tetraethyl-
benzimidazolylcarbocyanine iodide) and Griess reagent kit were
purchased from Invitrogen-Molecular probes (Burlington, ON,
Canada ). Caspases-3 and -9 inhibitors were purchased from
Calbiochem (La Jolla, CA, USA). Caspases-3 and -9 colorimetric
assay kits were obtained from Chemicon International (Temecula,
CA, U.S.A.), whereas the RayBioH Cell-Based p38 MAPK (Thr180/
Tyr182) ELISA Kit was from RayBiotech (Norcross, GA, U.S.A.).
[
3H]-Resveratrol (specific activity 0.3 to 0.6 Ci/mmole) was
purchased from Moravek Biochemicals Inc. (Brea, CA, USA).
Materials for quantitative real-time RT-PCR including the human
NOsignalling pathway RT
2profilerPCRarraywerepurchasedfrom
SABiosciences (Frederick, MD, U.S.A.). Unless otherwise stated, all
other compounds were purchased from Sigma-Aldrich (St. Louis,
MO, U.S.A.). Stock solutions (10
21M) of resveratrol and other drugs
were dissolved in dimethylsulfoxide (DMSO). This solvent at 0.03%
(v/v) has no effect by itself on cell survival (data not shown).
Human skin tissue
Human skin tissue was obtained from patients (female; n=3; 50,
60 and 65 years old) who were going to have plastic surgery (lifting).
Before surgical operation, patients were asked for their consent, if
the tissue removed during operation could be used for resveratrol
research studies. All human skin tissues used in this study were from
patients who hadgiventheir written consent.Additionally,thestudy
protocol and the consent form were approved by the Douglas
Institute Ethic committee. Informed written consent of patients was
obtained before tissue resection and the study was conducted
according to the Declaration of Helsinki Principles.
[
3H]-Resveratrol binding on human skin sections
Immediately after surgical removal, skin tissues were kept in
humidified (0.9% NaCl solution) pad at 4uC and transported to the
Douglas Mental Health University Institute. Tissues were immedi-
ately frozen in 2-methylbutane at 240uC for 15 sec and then kept at
280uC until needed. Human skin sections (16 mm) were obtained
using a cryomicrotome at 217uC, mounted on Fisher Superfrost
slides, dried overnight in a desiccator at 4uC, and then kept at
280uC until use. Receptor autoradiography was performed as
described in detail elsewhere [21]. Briefly, human skin sections were
incubated inthe presence of [
3H]-resveratrol at concentration of 25,
60 and 130 nM. Levels of [
3H]-resveratrol binding were quantified
using a MCID image analysis (St. Catherines, ON, Canada) Total
[
3H]-resveratrol binding was substracted from adjacent sections
incubated in the presence of 100 mM unlabelled resveratrol and
expressed as specific [
3H]-resveratrol binding (nCi/mg tissue, wet
weight). Competition binding assays were done at 30 nM of [
3H]-
resveratrol in the presence of increasing concentration of cold
resveratrol ranging from 0.1 nM to 100 mM.
At the end of the incubation period, human skin sections were
washed 4 times, one min each in cold Krebs-Ringer phosphate
buffer (KRP), rapidly dipped in cold water, fixed in 2.5% formalin
and 2.5% glutaraldehyde in phosphate buffered saline (PBS) for
10 min, washed in PBS and dehydrated in successive baths of 70%,
90%and100%ethanol(5 mineach).Sectionswereapposedagainst
KodakBiomaxMRfilms(PerkinElmer,Woodbridge,ON,Canada)
or liquid emulsion type NTB (Eastman Kodak, Rochester, NY,
USA) for eight months alongside with [
3H]-radioactive standards
(GE Healthcare Canada, Baie d’Urfe, QC, Canada).
Cell culture
HaCaT cells were prepared as described previously, with minor
modifications [38]. Briefly, HaCaT cells were cultured in HEPES-
buffered Dulbecco’s modified Eagle medium (DMEM) high
glucose, 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin. Cells were grown by removing the original medium
twice a week and replacing it with the medium of the same
composition until they reached confluence. Cells were then
removed from 75 cm
3 culture flasks by trypsinization (0.25%
trypsin in 0.02% EDTA-PBS) and seeded in either 6 well or 96
well plates (Corning Inc., Corning, NY, USA). Cultures were
maintained at 37uC in a humidified atmosphere (5% CO2 and
95% air) and used for experiments once they reached confluence.
[
3H]-Resveratrol binding on HaCaT cells
Binding assays were performed in HaCaT cells, once reached to
confluence in 6-well plates and each point was done in triplicate.
Cells were washed twice with cold KRP buffer and binding assays
were performed at 4uC by adding 2.5 ml of KRP buffer containing
[
3H]-resveratrol (0.5 to 600 nM) in the presence and absence of
100 mM cold resveratrol (non-specific binding). The binding
reaction was stopped by two rapid washes of 5 ml cold Krebs
buffer. Cells were lysed with 0.5 ml of 1N NaOH containing 1%
TritonX100 for 30 min and neutralized with 0.5 ml of 1N HCl.
Radioactivity was quantified using a beta counter with 45%
efficiency (Beckman Instruments, Meriden, CT, USA).
Calcein and MTT assays
SNP-induced toxicity was performed in HaCaT cells plated in
96 wells. On the day of the experiment, the medium was removed
and replaced with similar medium with SNP (0.3–3.0 mM) and
without FBS in the presence or absence of different drugs. Cell
viability was determined 24 hours later using both the calcein AM
and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) assays, as described previously [16,39].
SYTO 16 staining of apoptotic nuclei
Nuclear staining was performed using the fluorescent nuclear
dye SYTO 16. This method has been validated as an indicator of
apoptotic cell death [40]. Following a 24-hour exposure to SNP
(0.3–3 mM), culture medium was removed and cells were exposed
to phenol red-free DMEM medium containing SYTO 16 (2 mM)
for 30 min at 37uC. A microplate fluorescence reader (excita-
tion=485 nm; emission wavelength at 530 nm) was used to
automatically quantify the number of apoptotic HaCaT cells by
assessing the enhanced SYTO 16 staining.
Measurement of mitochondrial membrane potential
The mitochondrial inner membrane potential in immortalized
HaCaT cells was measured using the fluorescent dye 5,59,6,69-
tetrachloro-1,19,3,39 tetraethylbenzimidazolylcarbocyanine iodide
(JC-1), a cationic dye which is used as an indicator of mitochondrial
potential in cells [41]. In non-apoptotic cells with intact mitochon-
dria, JC-1 selectively enters the mitochondria where it aggregates
and exhibits a fluorescence emission at 590 nm. During loss of
mitochondrial membrane potential which features dying or
Resveratrol and Protection
PLoS ONE | www.plosone.org 10 September 2010 | Volume 5 | Issue 9 | e12935apoptotic cells, JC-1 diffuses throughout the cell and exhibits a green
fluorescence emission at 530 nm. Following a 24-hour exposure to
SNP (0.3–3 mM), culture medium was removed and cells were
exposed to phenol red-free DMEM containing JC-1 (3 mM) for
15 min at 37uC. Red/green fluorescence was measured using a
fluorescence plate reader (excitation/emission=550/600 nm and
excitation/emission=485/535 nm, respectively).
Measurement of intracellular ROS accumulation
Intracellular ROS levels were estimated in parallel to cell survival
using the 29,79-dichlorofluorescein diacetate (DCF-DA, 5 mM)
fluorescent dye, as previously described [16]. Briefly, the freely cell-
permeable DCF-DA was applied to the culture medium at the onset
of SNP exposure and is readily converted into 29,79-dichlorofluor-
escein which is then able to interact with intracellular free radicals
(primarily H2O2) to form the fluorescent dye DCF. DCF fluore-
scence was quantified after 5 hours (excitation=485 nm, emission=
530 nm) using a fluorescence plate reader.
Measurement of nitrite formation
Accumulation of nitrite (NO2
2) was measured in culture
medium by the Griess reaction using Invitrogen NO colorimetric
assay Kit, as described previously [16]. Briefly, cells were exposed
to SNP (1–3 mM) and resveratrol (1–30 mM) in DMEM without
FBS. Concentrations of nitrite, the end-product of NO production,
were quantified 5 hours later by adding 10 ml of Griess reagent (N-
(1-naphthyl)ethylenediamine and sulfanilic acid) to 75 ml sample of
cell culture medium according to the manufacturer’s protocol with
minor modifications. The optical density at 548 nm was measured
using a micro-plate reader. Nitrite concentrations were calculated
by comparison with the optical density of a nitrite solution
prepared in culture medium. The detection limit for nitrite
measurement in culture medium was 1 mM.
Measurement of caspases-3 and -9 activities
Caspase-3 and -9 activities were detected using the caspase-3 and
-9 colorimetric assay kits, respectively. Briefly, cells were exposed to
either vehicle or SNP (0.25–3 mM) alone during 24 hrs or in the
presence of resveratrol (1–30 mM). Cells were then lysed and briefly
centrifuged (10,000 g). Cytosolic extract was exposed to an assay
buffer in the presence of either the caspase-3 (Ac-DEVD-pNA) or
capase-9 (Ac-LEHD-CHO) substrate. The optical density at
405 nm was measured 1 hour later with a micro-plate reader.
Caspase-3 and -9 concentrations were calculated by comparison
with the optical density of a pNA standard prepared in buffer.
Measurement of p38 MAP kinase activity
The relative amount of p38 MAPK kinase was determined
according to manufacturer’s protocol using either anti-Phospho-
p38 MAPK (Thr180/Tyr182) or anti-p38-MAPK. HaCaT cells
were seeded into a 96 well tissue culture plate and exposed for
different times to SNP alone or in the presence of resveratrol. Cells
were then fixed and incubated with either anti-Phospho-p38
MAPK (Thr180/Tyr182) or anti-p38-MAPK. The wells were
then washed, and HRP-conjugated anti-mouse IgG was added to
the wells. The wells were washed again and a tetramethylbenzi-
dine (TMB) substrate solution was added to the wells and color
developed for 30 min in proportion to the amount of phosphor-
ylated form of p38 MAPK and total p38 MAPK. A stop solution
was finally added and changes in the optical density at 450 nm
were immediately measured using a micro-plate reader.
Quantitative real-time RT-PCR analysis
Expression of genes involved in NO signalling pathway was
measured using the two-step quantitative real-time human NO
signalling pathway RT
2 profiler
TM PCR array (PAHS-062A),
according to SABiosciences guidelines. Briefly, cells were
exposed to either vehicle or SNP (1 mM) in the presence or
absence of resveratrol (10 mM) for 24 hours. Total RNA from
each sample was isolated using the RNeasy Mini kit (Qiagen
(ONT, Canada). The TURBO
TM DNase from (Ambion,
Applied Biosystems, ONT, Canada) was then used to remove
trace quantities of DNA contamination from RNA samples
prior to RT-PCR. Reverse transcription of total RNA was
carried out with RT
2 first strand kit components and cDNA
generated was quantified with the RT
2 real-time PCR SYBRH
Green/ROX master using the Applied Biosystems 7500 Real
Time PCR System (CA, USA). Six housekeeping genes
including b-actin were used to normalize quantification of
mRNA target, and non-specific amplifications were verified by
dissociation curve. Each value represents the mean of triplicate
samples from two independent experiments.
Statistical analysis
All binding experiments were repeated 3–5 times (each in
triplicate) and binding parameters were determined using
GraphPad Prism program (version 4.03) (GraphPad Software
Inc., San Diego, CA, USA). Survival of vehicle-treated control
groups, not exposed to either SNP or various drugs was defined as
100%. A one-way ANOVA followed by Newman Keuls’ multiple
comparisons or unpaired Student’s t-tests were used to compare
control and treated groups, with p values ,0.05 being considered
as statistically significant. DDCt based fold-change of genes and
bounds of the 95% confidence interval were derived from the
average measures and calculated using the RT
2 Profiler
TM PCR
Array Data Analysis and compared to gene expression of the
control group. A minimal expression change of 3.0 and 0.3 fold
had to be reached to be considered as an up-regulated or down-
regulated candidate gene respectively.
Supporting Information
Table S1 Fold change and 95% confidence interval (95% CI) of
genes differentially expressed in HaCaT cells treated with
resveratrol (RSV, 10 mM alone and SNP (1 mM) alone or in
presence of RSV (10 mM). Fold change was compared to gene
expression of the control group.
Found at: doi:10.1371/journal.pone.0012935.s001 (0.07 MB
DOC)
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